| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Bristol-Myers Squibb |
| Information provided by: | Bristol-Myers Squibb |
| ClinicalTrials.gov Identifier: | NCT00046384 |
Purpose
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.
| Condition | Intervention | Phase |
|
Bipolar I Disorder |
Drug: aripiprazole |
Phase III |
| MedlinePlus related topics: | Bipolar Disorder |
| Drug Information available for: | Aripiprazole |
| Study Type: | Interventional |
| Study Design: | Treatment |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Patients with acute symptoms of Bipolar Disorder
Contacts and Locations| United States, Arizona | |||||
| Local Institution | |||||
| Scottsdale, Arizona, United States | |||||
| United States, Arkansas | |||||
| Local Institution | |||||
| Little Rock, Arkansas, United States | |||||
| United States, California | |||||
| Local Institution | |||||
| Chula Vista, California, United States | |||||
| Local Institution | |||||
| Pico Rivera, California, United States | |||||
| Local Institution | |||||
| San Diego, California, United States | |||||
| Local Institution | |||||
| Riverside, California, United States | |||||
| United States, District of Columbia | |||||
| Local Institution | |||||
| Washington, District of Columbia, United States | |||||
| United States, Florida | |||||
| Local Institution | |||||
| Winter Park, Florida, United States | |||||
| United States, New York | |||||
| Local Institution | |||||
| Staten Island, New York, United States | |||||
| United States, Oklahoma | |||||
| Local Institution | |||||
| Oklahoma City, Oklahoma, United States | |||||
| United States, Tennessee | |||||
| Local Institution | |||||
| Nashville, Tennessee, United States | |||||
| United States, Virginia | |||||
| Local Institution | |||||
| Falls Church, Virginia, United States | |||||
| United States, Washington | |||||
| Local Institution | |||||
| Bellevue, Washington, United States | |||||
| Argentina | |||||
| Local Institution | |||||
| Mendoza, Argentina | |||||
| Bristol-Myers Squibb |
More Information
BMS Clinical Trials Disclosure
|
|
For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm
|
| Study ID Numbers: | CN138-077 |
| First Received: | September 27, 2002 |
| Last Updated: | June 27, 2008 |
| ClinicalTrials.gov Identifier: | NCT00046384 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
